No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer.

Yun-Zi Wu,Ming Wu,Xiao-Hao Zheng,Bing-Zhi Wang,Li-Yan Xue,Shi-Kang Ding,Lin Yang,Jian-Song Ren,Yan-Tao Tian,Yi-Bin Xie

World journal of gastroenterology（2022）

引用 0|浏览8

暂无评分

摘要

Intraoperative sustained-release chemotherapy usage with 5-FU, did not improve the survival of patients who underwent an R0 radical resection in locally advanced stage of gastric cancer.

查看译文

关键词

5-year survival rate,Gastric cancer,Prognostic factor,R0 radical resection,Safety,Sustained-release 5-fluorouracil implants

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要